24/7 Wall Street
13 Sept 2026, 14:36 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
5 claims · each scored for market impact
Medtronic raised FY27 organic revenue guidance to 7.25%–7.75%, outperforming Abbott's reaffirmed range of 6.5%–7.5%. — Positive revenue acceleration and higher guidance typically drive short-term price appreciation for the affected company.
+0.40Abbott completed the $21 billion acquisition of Exact Sciences on March 23, 2026, to expand its diagnostics business. — Significant inorganic growth through a multi-billion dollar acquisition enhances long-term competitive moat and diversification.
+0.30Medtronic is planning a separation of its Diabetes business. — Corporate spin-offs or separations often act as catalysts for valuation re-ratings and unlocked shareholder value.
+0.30Continue reading
5 related stories
Search tags
Medtronic currently trades at a forward P/E of 15 and yields 3.11%, compared to Abbott's forward P/E of 17 and 2.4% yield. — While favorable for value investors, these are static valuation metrics rather than new catalysts.
Abbott reported a 9.8% decline in U.S. Structural Heart sales. — A decline in a specific high-value business segment signals localized weakness despite overall growth.
-0.10Which stocks this story touches
The author names it the winner for income investors due to higher yield, lower valuation, and accelerating organic growth.
Mentioned as a 'supercharging' acquisition for Abbott that fuels compounding growth.
While not the top pick for current income, it is praised for its diversification, durability, and superior long-term compound returns.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
9h ago
